http://www.bing.com:80/search?q=Create+SQL+SyntaxSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=Create+SQL+SyntaxCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://trials.arthritis.org/trials/NCT05288855Study Purpose The purpose of this study is to assess the efficacy and safety of voclosporin compared to placebo in achieving renal response following 24 weeks of therapy in adolescent and pediatric subjects with active lupus nephritis (LN).Sun, 05 Oct 2025 07:23:00 GMThttps://trials.arthritis.org/trials/NCT05843643- Clinical diagnosis of systemic lupus erythematosus (SLE) at least 24 weeks prior to screening as defined by the 2019 European Alliance of Associations for Rheumatology (EULAR)/ American College of Rheumatology (ACR) classification criteria for SLE.Fri, 05 Sep 2025 11:48:00 GMThttps://trials.arthritis.org/trials/NCT05956067Study Purpose Participants with chronic pain conditions including chronic low back pain and fibromyalgia may benefit from light stimuli presented to the retina to reduce chronic pain severity and pain sensitivity. Participants will be recruited into this study and will be presented with one of three uniform light stimuli via a wide-field ganzfeld in three conditions to determine the retinal ...Fri, 31 Oct 2025 11:32:00 GMThttps://trials.arthritis.org/trials/NCT03277989Inclusion Criteria: - Be 21 years of age or older at the time of surgery; - Diagnosed with unilateral and/or bilateral ankle joint disease; - Diagnosed with ankle joint damage from rheumatoid arthritis, post-traumatic, or degenerative arthritis; - Willing and able to consent to participate (written, informed consent; - Willing and able to attend the requested follow-up visits; - A clinical ...Sun, 10 Aug 2025 14:21:00 GMThttps://trials.arthritis.org/trials/NCT02062125This is a prospective study of scleroderma- spectrum patients focused on soft tissue calcinosis in order 1) to better understand the risk factors (including clinical/laboratory characteristics, and serology) of calcinosis in the scleroderma-spectrum disorders (limited or diffuse systemic sclerosis with or without overlap of inflammatory arthritis and/or myositis). 2) view common complications ...Sun, 29 Jun 2025 16:22:00 GMThttps://trials.arthritis.org/trials/NCT03974711Rampart Duo Clinical (RaDical) Post-Market Study Study Purpose This exempt, minimal risk, prospective, post-market, registry, multi-center, Institution Review Board (IRB) approved observational clinical evaluation will be conducted at up to a maximum of 20 investigation centers with no more than 200 study subjects being enrolled.Thu, 23 Oct 2025 21:42:00 GMT